ACADIA Pharma Inc

ACADIA Pharmaceuticals Inc.
(NASDAQ:ACAD) Shifts From Loss To Profit

It seems now is a pretty good time to review ACADIA Pharmaceuticals Inc.’s (NASDAQ:ACAD) . As it appears the company may be on the brink of some nontrivial accomplishments.

ACADIA Pharmaceuticals Inc., primary development efforts involve the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.

With the latest financial year loss and a trailing-twelve-month loss, the US$8.7b market-cap company amplified its loss by moving further away from its breakeven target.

Many investors are wondering about the rate at which ACADIA Pharmaceuticals will turn a profit. Below is the link to a high-level summary of the industry analysts’ expectations for the company.

The latest ACADIA Pharmaceuticals analysis

white printer paper with black text

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.